Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026
recent articles
From Diagnexia on LinkedIn: Delighted to share that Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026. A huge congratulations to our incredible team and partners for driving innovation and...
From Indica Labs: For researchers using in situ hybridization, optimization of both probing conditions and the analysis approach is necessary for the clearest results, yet the process of identifying the best values can be time consuming....
Philadelphia - October 27, 2026 - Proscia has entered into a collaborative agreement with Columbia University to identify biomarkers for neurodegenerative diseases, such as Alzheimer’s and other dementias. The collaboration pairs Columbia’s...
A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining tissue through...
Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology Seoul, South Korea and Miami, Florida,...
AI models in GI/liver pathology using the Aiforia Platform Quantitative and predictive AI models in gastrointestinal and liver pathology: the Mayo Clinic experience 4 November 2026 - 12:00 PM (noon) EST REGISTER NOW Over the...
